Literature DB >> 11941980

Remodeling the surgical approach to hepatocellular carcinoma.

Masatoshi Makuuchi1.   

Abstract

Surgery for hepatocellular carcinoma has improved during the last two decades, and the improvement is mainly attributable to various innovations in liver surgery, such as establishment of the precise criteria for surgical indications, development of ultrasound-guided hepatectomy, and additional use of portal vein embolization. Operative mortality has fallen below 2% in the 1990's, and the 5-year survival rate reached, according to the results of a nationwide survey, nearly 50%. More than 90% of the hepatectomies in the authors' institution are performed without whole blood transfusion, and mean hospital stay is approximately 23 days. Moreover, no-mortality hepatectomy has been achieved since 1993.

Entities:  

Mesh:

Year:  2002        PMID: 11941980

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  8 in total

1.  Geriatric assessment as a predictor of postoperative complications in elderly patients with hepatocellular carcinoma.

Authors:  Masaki Kaibori; Morihiko Ishizaki; Kosuke Matsui; Hiroya Iida; Kentaro Inoue; Fumio Nagashima; Masanori Kon
Journal:  Langenbecks Arch Surg       Date:  2016-02-23       Impact factor: 3.445

2.  Effects of implementing an "enhanced recovery after surgery" program on patients undergoing resection of hepatocellular carcinoma.

Authors:  Masaki Kaibori; Kosuke Matsui; Morihiko Ishizaki; Hiroya Iida; Kengo Yoshii; Hiroaki Asano; Masanori Kon
Journal:  Surg Today       Date:  2016-05-10       Impact factor: 2.549

3.  Zero mortality in more than 300 hepatic resections: validity of preoperative volumetric analysis.

Authors:  Shinji Itoh; Ken Shirabe; Akinobu Taketomi; Kazutoyo Morita; Norifumi Harimoto; Eiji Tsujita; Keishi Sugimachi; Yo-Ichi Yamashita; Tomonobu Gion; Yoshihiko Maehara
Journal:  Surg Today       Date:  2011-12-27       Impact factor: 2.549

4.  Strategies for resection using portal vein embolization: hepatocellular carcinoma and hilar cholangiocarcinoma.

Authors:  Daniel A Anaya; Dan G Blazer; Eddie K Abdalla
Journal:  Semin Intervent Radiol       Date:  2008-06       Impact factor: 1.513

Review 5.  Update on perioperative management of patients undergoing surgery for liver cancer.

Authors:  Masaki Kaibori; Kosuke Matsui; Mitsuo Shimada; Shoji Kubo; Kiyoshi Hasegawa
Journal:  Ann Gastroenterol Surg       Date:  2021-12-15

6.  Role of preoperative selective portal vein embolization in two-step curative hepatectomy for hepatocellular carcinoma.

Authors:  Wu Ji; Jie-Shou Li; Ling-Tang Li; Wu-Hong Liu; Kuan-Sheng Ma; Xiang-Tian Wang; Zhen-Ping He; Jia-Hong Dong
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

7.  Resection of hepatocellular cancer ≤2 cm: results from two Western centers.

Authors:  Sasan Roayaie; Khaled Obeidat; Carlo Sposito; Luigi Mariani; Sherrie Bhoori; Alessandro Pellegrinelli; Daniel Labow; Josep M Llovet; Myron Schwartz; Vincenzo Mazzaferro
Journal:  Hepatology       Date:  2013-01-25       Impact factor: 17.425

8.  Clinical outcomes of patients with a single hepatocellular carcinoma less than 5 cm treated with transarterial chemoembolization.

Authors:  Min Young Baek; Jeong-Ju Yoo; Soung Won Jeong; Jae Young Jang; Yong Kwon Kim; Shin Ok Jeong; Sae Hwan Lee; Sang Gyune Kim; Sang-Woo Cha; Young Seok Kim; Young Deok Cho; Hong Soo Kim; Boo Sung Kim; Yong Jae Kim; Su Yeon Park
Journal:  Korean J Intern Med       Date:  2018-10-26       Impact factor: 2.884

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.